Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析

◆英語タイトル:Aarti Drugs Ltd (AARTIDRUGS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH114893FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aarti Drugs Ltd (ADL), is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company’s products include active pharmaceutical ingredients, pharma intermediates, and specialty chemicals. Its active pharmaceutical ingredients comprise diclofenac potassium, diclofenac diethylamine, aceclofenac, diclofenac sodium, clopidogrel bisulphate, ornidazole, celecoxib, nimesulide, ofloxacin, secnidazole, and niacin, among others. ADL’s specialty chemicals include benzene sulphonic acid methyl ester, benzene sulphonamide, ortho para toluene sulphonamide, methyl nicotinate, and others. The company’s products are used in the therapeutic areas of anti-inflammatory, cardiovascular, anticoagulant, antidepressant, anti-cholestrol, antidiabetic, and antihyperphosphatemia. ADL is headquartered in Mumbai, Maharashtra, India.

Aarti Drugs Ltd Key Recent Developments

Feb 19,2021: Aarti drugs announces closure of subsidiary company
Oct 31,2020: Aarti Drugs to expand metformin capacity to 3000 TPM
May 16,2020: Aarti Drugs : Appointment of Director

This comprehensive SWOT profile of Aarti Drugs Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aarti Drugs Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Aarti Drugs Ltd – Key Information
Aarti Drugs Ltd – Overview
Aarti Drugs Ltd – Key Employees
Aarti Drugs Ltd – Key Employee Biographies
Aarti Drugs Ltd – Key Operational Heads
Aarti Drugs Ltd – Major Products and Services
Aarti Drugs Ltd – History
Aarti Drugs Ltd – Company Statement
Aarti Drugs Ltd – Locations And Subsidiaries
Aarti Drugs Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Aarti Drugs Ltd – Business Description
Aarti Drugs Ltd – Corporate Strategy
Aarti Drugs Ltd – SWOT Analysis
SWOT Analysis – Overview
Aarti Drugs Ltd – Strengths
Aarti Drugs Ltd – Weaknesses
Aarti Drugs Ltd – Opportunities
Aarti Drugs Ltd – Threats
Aarti Drugs Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Aarti Drugs Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Aarti Drugs Ltd, Key Information
Aarti Drugs Ltd, Key Ratios
Aarti Drugs Ltd, Share Data
Aarti Drugs Ltd, Major Products and Services
Aarti Drugs Ltd, History
Aarti Drugs Ltd, Key Employees
Aarti Drugs Ltd, Key Employee Biographies
Aarti Drugs Ltd, Key Operational Heads
Aarti Drugs Ltd, Other Locations
Aarti Drugs Ltd, Subsidiaries
Aarti Drugs Ltd, Key Competitors
Aarti Drugs Ltd, SWOT Analysis
Aarti Drugs Ltd, Ratios based on current share price
Aarti Drugs Ltd, Annual Ratios
Aarti Drugs Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The E. W. Scripps Company:戦略・SWOT・企業財務分析
    The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report Summary The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Opsona Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Opsona Therapeutics Ltd (Opsona) is a biopharmaceutical company that conducts research, develops and commercializes new treatment for the autoimmune and inflammatory diseases and cancers. The company's OPN-305 is a humanized antibody used to reduce pro-inflammatory cytokine production that i …
  • Evotec AG (EVT)-製薬・医療分野:企業M&A・提携分析
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • New Age Metals Inc:企業の戦略・SWOT・財務情報
    New Age Metals Inc - Strategy, SWOT and Corporate Finance Report Summary New Age Metals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Logitech International S.A.:企業の戦略・SWOT・財務分析
    Logitech International S.A. - Strategy, SWOT and Corporate Finance Report Summary Logitech International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Celanese Corporation:企業の戦略・SWOT・財務情報
    Celanese Corporation - Strategy, SWOT and Corporate Finance Report Summary Celanese Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • RCR Tomlinson Ltd (RCR):企業の財務・戦略的SWOT分析
    RCR Tomlinson Ltd (RCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Compania Espanola de Petroleos SAU-エネルギー分野:企業M&A・提携分析
    Summary Compania Espanola de Petroleos, S.A.U. (CEPSA) is an integrated energy company. It explores, produces, refines, transports and markets crude oil, petroleum products, and natural gas. It also produces and distributes electricity; manufactures, distributes, and sells basic petrochemicals, petr …
  • Pedernales Electric Cooperative, Inc.:発電所・企業SWOT分析
    Pedernales Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • UCB Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary UCB Inc (UCB), a subsidiary of UCB SA, is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, meta …
  • Deutsche Borse AG:企業のM&A・事業提携・投資動向
    Deutsche Borse AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Deutsche Borse AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Precision System Science Co Ltd (7707):企業の財務・戦略的SWOT分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company provide products such as automated nucleic acid isolation system, large sample volume nucleic acid extract …
  • Baraka Energy & Resources Ltd (BKP):石油・ガス:M&Aディール及び事業提携情報
    Summary Baraka Energy & Resources Ltd (Baraka Energy), formerly Baraka Petroleum Ltd, is an oil and gas exploration and development company that offers oil and gas exploration and production services. The company explores, identifies, and develops energy and resource assets. It has oil and gas asset …
  • National Presto Industries Inc (NPK):企業の財務・戦略的SWOT分析
    Summary National Presto Industries Inc (National Presto) operates as a consumer product manufacturer that provides pressure cookers and electric appliances. The company provides products such as clocks and timers, coffee makers, bacon cookers, canners, curly cutters, deep fryers, griddles, grills, d …
  • Grieg Seafood ASA:企業の戦略・SWOT・財務情報
    Grieg Seafood ASA - Strategy, SWOT and Corporate Finance Report Summary Grieg Seafood ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Renco Group SpA:企業の戦略的SWOT分析
    Renco Group SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Vietnam Prosperity Joint-Stock Commercial Bank (VPB):企業の財務・戦略的SWOT分析
    Vietnam Prosperity Joint-Stock Commercial Bank (VPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Sygnity SA (SGN):企業の財務・戦略的SWOT分析
    Sygnity SA (SGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Medeon Biodesign Inc (6499):医療機器:M&Aディール及び事業提携情報
    Summary Medeon Biodesign Inc (Medeon Biodesign) is a medical device company that develops patient-centered medical device products that address unmet medical needs. The company’s products include cardiovascular devices and equipment, devices for minimally invasive surgeries, laparoscopic device, hig …
  • Clayton General Inc:企業の戦略的SWOT分析
    Clayton General Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆